mesowatch
HomeTalc Claimants Fight to Dismiss J&J Bankruptcy
divider

Talc Claimants Fight to Dismiss J&J Bankruptcy in High-Stakes Battle

courtroom battle with judge

In a gripping culmination to the high-stakes legal battle, two committees representing talc injury claimants in the Chapter 11 case of Johnson & Johnson’s talc unit laid out their fervent arguments for the dismissal of the bankruptcy case before a New Jersey judge on Thursday. Ian Shapiro of Cooley LLP, representing the committee for mesothelioma claimants, delivered a scathing indictment, asserting that the bankruptcy filing favored J&J’s interests over those of the talc claimants, casting a shadow of suspicion over the company’s motives.

Shapiro’s impassioned plea resonated through the courtroom as he contended that J&J possessed ample resources to weather the storm of 38,000 tort claims without resorting to bankruptcy. He asserted that the filing served as a strategic maneuver to shield the parent company’s assets from potential recovery, leaving talc claimants in the lurch.

Echoing Shapiro’s sentiments, David J. Molton of Brown Rudnick LLP, representing the ovarian cancer claimants committee, painted a damning portrait of J&J’s machinations. Molton dissected the intricate web of corporate transactions that culminated in the creation of LTL Management LLC, arguing that the divisive merger was engineered to safeguard the parent company’s interests at the expense of talc claimants.

Molton highlighted the pivotal role of the landmark Ingham case, which saw J&J facing a monumental verdict before embarking on a desperate quest to extricate itself from talc liabilities. He revealed the company’s failed attempt to settle talc claims through the bankruptcy of its supplier, Imerys Talc America, before resorting to the divisive merger strategy.

As the courtroom drama unfolded, tensions ran high as testimony from LTL’s expert witnesses shed light on the mounting financial strain faced by Johnson & Johnson. Accounting expert Gregory Knox Bell underscored the subsidiary’s cash-flow woes, laying bare the toll exacted by the talc liabilities.

In a compelling argument, Jeffrey Sponder of the U.S. Trustee’s Office cast doubt on the integrity of LTL’s leadership, decrying the lack of independence among its officers and directors. Sponder urged the court to dismiss the case or appoint a Chapter 11 trustee to mitigate the glaring conflicts of interest.

As the proceedings drew to a close, the fate of LTL’s bankruptcy hung in the balance, with U.S. Bankruptcy Judge Michael B. Kaplan poised to deliver a verdict in the coming days. Against a backdrop of legal brinkmanship and corporate intrigue, the courtroom saga reached a crescendo, leaving observers on the edge of their seats.

Johnathan Edwards

Reading Time: 1 mins

Published On: February 17, 2022

Johnathan Edwards - author

Johnathan Edwards Is a husband, father, veteran and medical writer, from the state of California. After serving 9 years in the U.S Army Medical Department, John cultivated his passion for serving his country and helping people. He often volunteers with helping to rehabilitate veterans of all ages. After John’s father was diagnosed with Mesothelioma, he began to research, write and fight for ways to help other victims of asbestos exposure.

More to Read

Section Divider

Katie Duquette - December 20, 2024

The Asbestos Lawsuit Process: From Diagnosis to Legal Action

Mini Divider
Mesowatch Logo

Mesowatch serves as an industry watchdog and advocates for patients and families affected by asbestos by providing reliable and up-to-date news stories and information on asbestos and mesothelioma.

NAVIGATE

About UsEditorial GuidelinesNewsSupport and ResourcesPrivacy PolicySitemap

CONTACT US

Email: support@mesowatch.com

Phone: (866) 402-1000

Address: 3260 N Hayden Rd, Suite 210, Scottsdale, AZ 85251

Copyright © 2024 by Mesowatch. All Rights Reserved.
At Mesowatch, we strive to provide helpful information for your journey. Please remember that the content on our website is for informational purposes only and is protected by copyright law. It is not a substitute for professional medical or legal advice. We encourage you to consult qualified professionals for any health or legal concerns. Disclaimer